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Background/aim: Renal function of patients with hypothyroidism increases after reaching euthyroid state. There is no data regarding
geriatric age group. The aim of the study was determined to investigate whether renal function of geriatric patients with hypothyroidism
increases after they become euthyroid.
Materials and methods: Patients who were sixty-five years or older were retrospectively screened in two centers. TSH, T3, T4, creatinine,
and eGFR calculated by CKD-EPI formula were recorded under the presence of accompanying hypothyroidism. The same variables
were recorded after the patients became euthyroid.
Results: 285 patients were included in the study, the median age was 73(65–84), and 234 patients were female. Patients were examined in
four groups according to TSH values. There were 160 (56.1%) patients with TSH 5–9.9 uIU/mL, 60(21.1%) patients with TSH between
10–19.9 uIU/mL, 41(14.4 %) patients with TSH between 20–49.9 uIU/mL and 24(8.4%) patients with TSH> 50uIU/mL. There was a
significant and negative correlation between the initial TSH values and the first calculated eGFR values (p: 0.001; r: –0.191). The median
eGFR of the patients in hypothyroid cases was 66.59 (14.62–116.07), while the median eGFR value of patients was 69.6 (12.91–109.31)
in the euthyroid state. This value obtained after thyroid replacement was significantly improved when compared to the first eGFR (p:
0.001). In logistic regression analysis, pretreatment TSH value was found to independently affect eGFR (p: 0.009; Exb: 1.017).
Conclusion: It has been observed that hypothyroidism treatment increases eGFR in geriatric patients. Similar results were obtained
after studies with younger patients in the literature. This study is a study in which only geriatric age group patients were examined. It
should be kept in mind that hypothyroidism which is not corrected in geriatric patients may also contribute to a decrease in eGFR.
Key words: Hypothyroidism, older, renal

1. Introduction
Thyroid hormone interacts with all systems. In addition
to its effect on all systems, it plays a role in the growth
and development of the kidneys. It also regulates water
and sodium balance [1]. Due to its effect on the kidney,
it also regulates renal plasma flow (RPF) and glomerular
filtration rate (eGFR). Hyponatremia with decreased RPF
and eGFR are common in patients with hypothyroidism.
It has been observed that these disorders improve with
thyroid replacement therapy [2]. It has been shown in the
literature that L-thyroxine can correct acute renal failure
and that underlying chronic renal failure rapidly worsens
in patients with hypothyroidism [3,4].
Thyroid disorders affect all systems, primarily the
cardiovascular and renal systems [5]. The renin-angiotensin

system (RAS) functions to control cardiovascular and
renal function. Thyroid hormones play an important
role in the growth and development of various tissues,
including kidney and lung, which are the main sites of
renin and ACE synthesis.
Hypothyroidism is a disease that is more common
in older people than young people and is more common
among women than men. The incidence increases with age.
In a study that evaluated more than 25,000 people, it was
found that 10% of men aged 65 to 74 and 16% of women
had TSH levels above the normal limit. It was observed
that TSH levels increased in 16% of men aged 75 and
over, and 21% of women [6]. In the latest National Health
& Nutrition Examination Survey (NHANES) study, agespecific analysis of measured TSH levels and antithyroid
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antibody titers, without evidence of autoimmune
thyroiditis, showed that 12% of subjects aged 80 and over
had TSH levels greater than 4.5 mIU/L [7].
Old age is considered to be a risk factor for chronic
kidney disease (CKD), but the decrease in the eGFR with
aging may be a consequence of the normal aging process
and not a sign of disease.
Although correction of hypothyroidism has been
shown to have a positive effect on eGFR [8], no previous
studies have been conducted in older patients. In this
study, it was aimed to examine the change in kidney
functions of older patients with hypothyroidism after they
became euthyroid.
2. Materials and methods
2.1. Study subjects
This study was conducted in two centers, one of which
was a university hospital and the other was a government
hospital. In the last 10 years, 1151 patients who were
admitted to Geriatric Medicine and Endocrinology
outpatient clinics with hypothyroidism diagnosis were
retrospectively examined. Patients under 65 years of
age and patients without TSH and creatinine values
were excluded from the study. As a result, the results of
285 patients were examined. The local ethics committee
approved the study.
2.2. Laboratory tests
Free T3 (fT3), free T4 (fT4), TSH, creatinine, and eGFR
measurements were examined in both hypothyroid and
euthyroid states. Although it changed according to the
initial TSH values of the patients, The duration of TSH
groups to become euthyroid state is between 10–14 weeks.
For patients who became euthyroid, the normal TSH value
was determined as the value within the normal reference
range of the laboratory. The eGFR was calculated using
the chronic kidney disease epidemiology collaboration
equation (CKD-EPI). The CKD-EPI equation was
developed to find a more precise formula than serum
creatinine and other preset clinical parameters when the
eGFR is > 60 mL/min per 1.73 m2. The CKD-EPI equation
performed better than the MDRD (modification of diet in
renal disease study) equation.
The CKD-EPI equation:
eGFR = 141 * min(Scr/κ,1)α * max(Scr/κ, 1)
–1.209 * 0.993 age * 1.018 [if female] * 1.159 [if black]
(Scr is serum creatinine (mg/dL), κ is 0.7 for females
and 0.9 for males, α is –0.329 for females and –0.411 for
males), min indicates the minimum of Scr/κ or 1, and max
indicates the maximum of Scr/κ or 1) [9].
Serum levels of fT3 (normal 3.8–6 pmol/L), fT4
(normal 7.86–14.41 pmol/L) and TSH (normal 0.38–5.33
mIU/mL) were measured by a paramagnetic particle
chemiluminescent immunoassay using the UniCel DxI
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800 Immunoassay System (Beckman Coulter, USA).
Serum creatinine was measured by Jaffe method at AU
5800 (Beckman Coulter, USA).
2.3. Statistical analyses
Distribution of the continuous variables was determined
by the Kolmogorov–Smirnov test. Continuous variables
with normal distribution were expressed as mean ± SD.
Variables with skew distribution were expressed as median
(minimum-maximum) and categorical variables were
expressed as percentage. The paired sample t-test was
used for normally distributed variables. The Wilcoxon test
was used to compare dependent variables that were not
normally distributed. Pearson and Spearman analysis was
used to identify correlations between study parameters.
To compare the parameters which were not normally
distributed the Kruskal–Wallis tests were conducted.
The Mann–Whitney U test was performed to test the
significance of pairwise differences using Bonferroni
correction to adjust for multiple comparisons. Linear
regression analysis and logistic regression analysis were
statistical methods used to find factors that independently
affect glomerular filtration rate. For all statistics, a twosided p value < 0.05 was considered to be statistically
significant. All analyses were performed with SPSS v: 22.0
for Windows (SPSS Inc, Chicago, IL).
3. Results
285 patients were included in our study. The median age
was 73 (65–94) years. Patients were divided into four
groups according to their TSH values. There were 160
patients (56.1%) with TSH value between 5–9.9 μIU/
mL, 60 patients (21.1%) with a TSH value between 10–
19.9 μIU, 41 patients (14.4%) with a TSH value between
20–49.9 μIU/mL and 24 patients (8.4%) with TSH >50
μIU/mL. 234 patients were female and 51 were male.
Demographic characteristics are shown in Table 1. There
was a statistically significant negative correlation between
the TSH value in the baseline hypothyroid phase and the
eGFR values at that time (p: 0.001; r: –0.191). Furthermore,
there was a significant and negative correlation between
the TSH levels and the eGFR values at the time patients
became euthyroid (p: 0.016; r: –0.155). The median eGFR
of the patients with hypothyroid status was 66.59 (14.62–
116.07), while the median eGFR value of the patients with
euthyroid status was 69.6 (12.91–109.31). The difference
between these values after thyroid replacement was
statistically significant (p: 0.001). These differences are
shown in Table 2. The difference between TSH values at
baseline and at the end of treatment was also significant
(p: 0.001).
Initially, patients were divided into 4 different
groups according to TSH values. There was a significant
difference between these groups in terms of eGFR values
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by the Kruskal–Wallis test (0.017). Post-hoc analyses
were performed to determine which group lead to this
significance. The difference between the groups analyzed
by Mann–Whitney U test after post-hoc analysis was
considered significant if the p-value was below 0.008.
The results revealed that the difference was caused by the
difference between the first and fourth groups of TSH
values and the second and fourth groups of TSH values (p:
0.006; p: 0.005, respectively). These significant differences
are shown in Table 3. eGFR changes in four TSH groups
before and after treatment were examined. eGFR change in
the 4th group was highest. Similarly, whether the change
in eGFR before and after treatment was different between
TSH groups was examined with the Kruskal–Wallis test.
There was a statistically significant difference between the
groups (p: 0.001). It was seen that this difference originated
from the 4th group (p: 0.001). The median eGFR change in
group 4 was 12.47 mL/min/m2. The graph of the change
between TSH groups is shown in Figure.
When the factors affecting eGFR changes before and
after treatment were wanted to be examined by linear
regression analysis, age, pre-treatment TSH value and posttreatment TSH value were included in the model. It was
observed that the increase in eGFR was higher in patients
with higher TSH values before thyroid replacement
therapy (p: 0.001). Similarly, when patients with and
without increased eGFR before and after treatment
were dichotomized and logistic regression analysis was
performed, it was observed that there was an increase in
eGFR in patients with high TSH values before treatment
(p: 0.009; Exb: 1.017). Regression analyzes are shown in
Table 4.
4. Discussion
In this study, we wanted to evaluate the effect of
hypothyroidism on renal functions in older patients. The
results of this study revealed an improvement in renal
function and an increase in GFR after correcting thyroid
functions. The group with the greatest improvement

in eGFR after becoming euthyroid was the group with
the highest baseline TSH levels (TSH > 50 μIU/mL)
at baseline. In the literature, there are studies with
heterogeneous patient groups examining the effects of
thyroid replacement therapy on renal functions. Our study
is important because this is examining only the geriatric
patient group. Due to changes in the renal function of
the older patients, this issue needs to be studied in the
older group. This study fills this gap in the literature and
Table 2. eGFR and TSH changes before and after treatment.
Before
treatment
66.59(14.62–
116.07) mL/dk
18.15 ± 22.39
uIU/mL

eGFR
TSH

After
P value
treatment
69.6(12.91–
0.001
109.31) mL/dk
2.6 ± 1.5 uIU/
0.001
mL

*eGFR: estimated glomerular filtration rate, TSH: thyroid
stimulating hormone.
Table 3. eGFR differences between groups before treatment.
TSH groups eGFR

P value : 0.017

1

69.27 (15.02–166.07) mL/dk

2

68.88 (14.62–110.8) mL/dk

3

64.82 (29.20–90.13) mL/dk

4

57.43 (22.45–94.96) mL/dk

* eGFR: estimated glomerular filtration rate, TSH: thyroid
stimulating hormone.
1 : Group 1 TSH 5–9.9 uIU/mL ; 2: Group 2 TSH 10–19.9 uIU/
mL; 3: Group 3 TSH 20–49.9 uIU/mL; 4: Group 4 TSH > 50 uIU/
mL There was a statistically significant difference between the
groups ;( p: 0.007).
When the statistical significance was sought from the group,
Bonferroni correction was accepted as p < 0.008. According
to this, statistical significance was found between the 1st and
4th groups and the 2nd and 4th groups (p: 0.006, p: 0.005
respectively).

Table 1. Demographic features.
Age
Age

Center 1

Center 2

TSH Group 1 TSH Group 2 TSH Group 3

TSH Group 4 Total

73(65–89)

74(65–94)

74(65–94)

73(65–93)

72(65–85)

72.5(65–86)

Male

73(66–93)

148

22

22

14

8

7

51

Female

73(65–94)

29

86

138

46

33

17

234

Total

73(65–94)

177

108

160

60

41

24

285

*TSH: thyroid stimulating hormone.
1 : Group 1 TSH 5–9.9 uIU/mL; 2: Group 2 TSH 10–19.9 uIU/mL; 3: Group 3 TSH 20–49.9 uIU/mL; 4: Group 4 TSH >50 uIU/mL.
**Center 1 : Hacettepe University, Ankara ,Turkey; Center 2 : Keçiören Training and Resarch Hospital, Ankara, Turkey.
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Figure. eGFR changes of patients after treatment of according to TSH groups.
Table 4. Factors affecting eGFR changes.
Model 1* linear regression
P value Beta
analysis

95% CI

eGFR change
Age

0.497

0.040

–0.111–0.229

Pretreatment TSH

0.001

0.209

0.045–0.154

Posttreatment TSH
0.697
0.023
–0.649–0.969
The model fit was assessed using appropriate residual and
goodness-of-fit statistics. (F sig : 0.001)
Model 2** logistic
ExB
regression analysis
eGFR change
Age

0.312

1.017

0.984–1.051

Pretreatment TSH

0.009

1.017

1.004–1.031

Posttreatment TSH

0.746

0.260

0.876–1.204

Hosmer and Lemeshow goodness of fit statistics were used to
assess model fit (p: 0.086).
eGFR: estimated glomerular filtration rate, TSH: thyroid
stimulating hormone.
* GFR change was taken as a numerical variable and linear
regression was performed.
** Before and after treatment, patients with or without increased
GFR were dichotomized and logistic regression was performed.
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demonstrates that the improvement in thyroid functions
also improves renal functions.
The results in the literature suggest that the subclinical
form of hypothyroidism may also be associated with
decreased eGFR and a high prevalence of chronic kidney
disease [10–14]. The results of this present study support
these observations and suggest that low thyroid function
within the clinically normal range is associated with
reduced GFR. In addition, thyroid function, which is within
normal limits, is positively associated with effective renal
plasma flow, a measure of renal blood flow [13,15]. After
treatment of hypothyroidism with T4 therapy, increased
renal blood flow was observed. Thus, renal blood flow
may mediate the relationship between thyroid function
and GFR. Since high vascular resistance and low cardiac
output are the vascular consequences of hypothyroidism, a
decrease in renal blood flow may ocur [2,16]. On the other
hand, it is also possible for kidney function to affect the
thyroid. Therefore, renal dysfunction may cause elevated
serum iodine levels and observations in patients with
end-stage renal disease suggest that iodine restriction may
improve hypothyroidism in these patients [2]. There are
studies suggesting that autoimmune thyroid disease may
lead to immunocomplex accumulation in renal glomeruli
[2]. In our study, autoantibody levels of patients were not
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determined. Therefore, we cannot make an inference to
support this information.
Histological changes in nephrons, especially basement
membrane thickening, have been demonstrated in both
hypothyroid rats and humans. These changes can lead to
changes in renal hemodynamics, reductions in renal blood
flow, physiological effects that reduce GFR and, therefore,
creatinine clearance [17–19].
Lo et al. investigated the prevalence of hypothyroidism
at different levels of predicted GFR. In this study, it was
found that low GFR was associated with a higher prevalence
of hypothyroidism [20]. Shin et al. evaluated the effect of
LT4 treatment on stage 2–4 CKD patients, suggesting that
LT4 decreases renal function decline in CKD patients with
subclinical hypothyroidism [21]. Arora et al. Found that
46 patients with hypothyroidism had significantly reduced
serum creatinine levels in response to 6 weeks of treatment
with thyroxine [22]. In our study, there were 30 patients
with creatinine levels above normal, and 9 of them showed
a significant decrease in creatinine levels after treatment.
The RAS system may be one of the factors explaining
renal recovery from LT4 replacement. It is known that
thyroid hormones stimulate renin mRNA through
mechanisms dependent on the renin hormone regulatory
element [23]. Thyroid hormone can also affect tubular
functions. T3 increases the expression of mRNA encoding
Na+/K+-ATPase. For this reason, hyponatremia may
be seen due to increased sodium urinary excretion. It
is therefore important to distinguish TSH values when
making the differential diagnosis of hyponatremia.
The number of patients in our study is sufficient to
make an adequate inference. Some limitations of this study
should be addressed. Since this was a retrospective study,
a screening was performed on the hospital records. There
are many factors that may impair renal function in older
patients. The first of these are the reasons for not getting
enough fluid, using multiple NSAIDs, antihypertensive

drugs, diuretics, prostate problems in male patients.
In our database, there was no record of the patients’
possible problems. For this reason, we could not observe
adequate recovery after thyroid replacement in some
patients. In some patients, creatinine levels increased and
GFR values decreased. It was thought that the reason for
this is not known whether or not the causes of possible
renal dysfunction are mentioned above. However, we
cannot ignore the possibility of hypothyroidism causing
glomerulosclerosis and permanently impairing kidney
function, as shown by studies. As a result of our study, we
cannot say for sure that hypothyroidism may lead to direct
renal injury in geriatric patients, but it is clear that there is
a correlation between GFR and thyroid functions. Further
prospective studies are needed to make clear conclusions
regarding this issue.
As a conclusion, to the best of our knowledge, this study
is important in that it is a study in which only geriatric
patients were examined and showed that renal functions
could improve after hypothyroidism treatment. The high
significance of the results and the large study population
are the strengths of this study. It should be kept in mind
that decreased renal function and thyroid disorders may
have a link in older age. Screening TSH levels should be
a routine part of geriatric assessment. Moreover, renal
function of geriatric patients should be re-assessed after
giving hypothyroidism treatment and achieving euthyroid
state.
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